This study investigates the treatment of pancreatic duct adenocarcinoma. It involves evaluating a combination of therapies for individuals with this condition.
The purpose of this study is to evaluate how safe and effective the treatments are for patients. It looks at the combination of different therapies to see how well they work together.
- Who can participate: Adults with biopsy-proven locally advanced or metastatic pancreatic duct adenocarcinoma can participate. Participants should not have had prior systemic therapy, except under specific conditions, and must meet certain health criteria.
- Study details: Participants will undergo specific treatments and follow-up visits. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand